Kushner SA - Search Results

1

A novel strategy for the treatment of cocaine addiction.

Dewey SL, Morgan AE, Ashby CR Jr, Horan B, Kushner SA, Logan J, Volkow ND, Fowler JS, Gardner EL, Brodie JD. Dewey SL, et al. Among authors: kushner sa. Synapse. 1998 Oct;30(2):119-29. doi: 10.1002/(SICI)1098-2396(199810)30:2<119::AID-SYN1>3.0.CO;2-F. Synapse. 1998. PMID: 9723781

2

Implication of the GABA(B) receptor in gamma vinyl-GABA's inhibition of cocaine-induced increases in nucleus accumbens dopamine.

Ashby CR Jr, Rohatgi R, Ngosuwan J, Borda T, Gerasimov MR, Morgan AE, Kushner S, Brodie JD, Dewey SL. Ashby CR Jr, et al. Synapse. 1999 Feb;31(2):151-3. doi: 10.1002/(SICI)1098-2396(199902)31:2<151::AID-SYN8>3.0.CO;2-W. Synapse. 1999. PMID: 10024012

3

Gamma-vinyl GABA attenuates cocaine-induced lowering of brain stimulation reward thresholds.

Kushner SA, Dewey SL, Kornetsky C. Kushner SA, et al. Psychopharmacology (Berl). 1997 Oct;133(4):383-8. doi: 10.1007/s002130050418. Psychopharmacology (Berl). 1997. PMID: 9372539

4

The irreversible gamma-aminobutyric acid (GABA) transaminase inhibitor gamma-vinyl-GABA blocks cocaine self-administration in rats.

Kushner SA, Dewey SL, Kornetsky C. Kushner SA, et al. J Pharmacol Exp Ther. 1999 Aug;290(2):797-802. J Pharmacol Exp Ther. 1999. PMID: 10411594

5

Chronic cocaine administration decreases the functional coupling of GABA(B) receptors in the rat ventral tegmental area as measured by baclofen-stimulated 35S-GTPgammaS binding.

Kushner SA, Unterwald EM. Kushner SA, et al. Life Sci. 2001 Jul 20;69(9):1093-102. doi: 10.1016/s0024-3205(01)01203-6. Life Sci. 2001. PMID: 11508652

6

In vivo SPECT imaging of 5-HT1A receptors with [123I]p-MPPI in nonhuman primates.

Kung HF, Frederick D, Kim HJ, McElgin W, Kung MP, Mu M, Mozley PD, Vessotskie JM, Stevenson DA, Kushner SA, Zhuang ZP. Kung HF, et al. Among authors: kushner sa. Synapse. 1996 Nov;24(3):273-81. doi: 10.1002/(SICI)1098-2396(199611)24:3<273::AID-SYN10>3.0.CO;2-Y. Synapse. 1996. PMID: 8923668

7

Specificity of diastereomers of [99mTc]TRODAT-1 as dopamine transporter imaging agents.

Meegalla SK, Plössl K, Kung MP, Stevenson DA, Mu M, Kushner S, Liable-Sands LM, Rheingold AL, Kung HF. Meegalla SK, et al. J Med Chem. 1998 Feb 12;41(4):428-36. doi: 10.1021/jm970742b. J Med Chem. 1998. PMID: 9484494

8

Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents.

Meegalla SK, Plössl K, Kung MP, Chumpradit S, Stevenson DA, Kushner SA, McElgin WT, Mozley PD, Kung HF. Meegalla SK, et al. Among authors: kushner sa. J Med Chem. 1997 Jan 3;40(1):9-17. doi: 10.1021/jm960532j. J Med Chem. 1997. PMID: 9016323

9

Kinetic modeling of [99mTc]TRODAT-1: a dopamine transporter imaging agent.

Kushner SA, McElgin WT, Kung MP, Mozley PD, Plössl K, Meegalla SK, Mu M, Dresel S, Vessotskie JM, Lexow N, Kung HF. Kushner SA, et al. J Nucl Med. 1999 Jan;40(1):150-8. J Nucl Med. 1999. PMID: 9935071 Free article.

10

Simplified reference region model for the kinetic analysis of [99mTc]TRODAT-1 binding to dopamine transporters in nonhuman primates using single-photon emission tomography.

Acton PD, Kushner SA, Kung MP, Mozley PD, Plössl K, Kung HF. Acton PD, et al. Among authors: kushner sa. Eur J Nucl Med. 1999 May;26(5):518-26. doi: 10.1007/s002590050420. Eur J Nucl Med. 1999. PMID: 10382097

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

146 results

Search Page